Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study

This study has been completed.
Sponsor:
Collaborator:
Sanofi
Information provided by:
University of Zurich
ClinicalTrials.gov Identifier:
NCT01038011
First received: December 15, 2009
Last updated: February 2, 2010
Last verified: February 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: August 2006
  Estimated Primary Completion Date: No date given